Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Legislative Update — Week of Aug. 26, 2024

  • Post author:PacConAdmin
  • Post published:August 26, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

During the second session of the 118th Congress, FDAnews will track important pending legislation, that has been acted on by Dec. 31, 2023 to keep you updated on laws and…

Continue ReadingLegislative Update — Week of Aug. 26, 2024

Quick Notes: M&A, Divestitures and Collaborations — Aug. 26, 2024

  • Post author:PacConAdmin
  • Post published:August 26, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

This edition of Quick Notes features announcements of Baxter’s agreement to sell its Vantive Kidney care segment, Merck’s B-Cell depletion therapy acquisition, Triastek collaboration with BioNTech and Crown Laboratories and…

Continue ReadingQuick Notes: M&A, Divestitures and Collaborations — Aug. 26, 2024

Do Not Use Recalled Chest Compression Device, FDA Warns

  • Post author:PacConAdmin
  • Post published:August 26, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

Debfitech has issued an urgent medical device safety removal letter to its customers of the RMU-2000 ARM XR chest compression device, which provides chest compressions on adults whose hearts suddenly…

Continue ReadingDo Not Use Recalled Chest Compression Device, FDA Warns

Members of Congress Question FDA on Troubling Biopharma Research in China

  • Post author:PacConAdmin
  • Post published:August 26, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

Citing ethical and data concerns, four US lawmakers have begun an investigation into clinical research conducted jointly by American biopharma firms and the Chinese military, as well as trials run…

Continue ReadingMembers of Congress Question FDA on Troubling Biopharma Research in China

Regulatory Update — Week of Aug. 19, 2024

  • Post author:PacConAdmin
  • Post published:August 23, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

This week, the FDA published final guidance on product-specific guidance meetings between FDA and ANDA applicants and an electronic submission template for medical device de novo requests. Draft guidance was…

Continue ReadingRegulatory Update — Week of Aug. 19, 2024

Quick Notes: EU Edition — Aug. 23, 2024

  • Post author:PacConAdmin
  • Post published:August 23, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

In this edition of Quick Notes EU, we note a revised EMA guideline on pharmacovigilance, a call by EMA to revoke authorization of Ocaliva for treatment of primary biliary cholangitis…

Continue ReadingQuick Notes: EU Edition — Aug. 23, 2024

Lack of CAPAs, MDRs, Complaint Follow-Up, Earn Globus a Warning Letter

  • Post author:PacConAdmin
  • Post published:August 23, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

Globus Medical, a manufacturer of surgical robots, received an FDA Warning Letter after the company’s inadequate response failed to address findings regarding screws misplaced during surgeries, lack of correction and…

Continue ReadingLack of CAPAs, MDRs, Complaint Follow-Up, Earn Globus a Warning Letter

FDA Finalizes Guidance on Electronic Submissions for De Novo Devices

  • Post author:PacConAdmin
  • Post published:August 23, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

The FDA outlines what goes into a De Novo device request filed using the electronic Submission Template and Resource (eSTAR), in a final guidance released Thursday. Source: Drug Industry Daily

Continue ReadingFDA Finalizes Guidance on Electronic Submissions for De Novo Devices

Battery Life Defect for Plum Infusion Systems Prompts Recall

  • Post author:PacConAdmin
  • Post published:August 22, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

ICU Medical is updating the use instructions for the Plum 360, Plum A+ and Plum A+3 Infusion Systems due to a manufacturing defect of the batteries, which can substantially diminish…

Continue ReadingBattery Life Defect for Plum Infusion Systems Prompts Recall

Quick Notes: Drug Research and Development — Aug. 22, 2024

  • Post author:PacConAdmin
  • Post published:August 22, 2024
  • Post category:Uncategorized
  • Post comments:0 Comments

In this edition of Quick Notes, we look at positive news on development of drugs and treatments for multiple myeloma, RSV and follicular lymphoma as well as the discontinuation of…

Continue ReadingQuick Notes: Drug Research and Development — Aug. 22, 2024
  • Go to the previous page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 328
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.